| Global Infectious Disease Treatment Market 2011-2014 |
| Publication Date |
Feb 2012 |
| Publisher |
Infiniti Research Ltd |
| Product Type |
Report |
| Pages |
34 |
| Single User License |
$
1500.00 |
| Site User License |
$
1700.00 |
| Corporate User License |
$
2500.00 |
|
|
Reportstack.com does not charge credit card fee, transaction charges, extra tax or VAT on any purchase. |
TechNavio’s analysts forecast the Global Infectious Disease Treatment market to grow at a CAGR of 8.1 percent over the period 2011–2014. One of the key factors contributing to this market growth is the increase in prevalence of infectious diseases. The Global Infectious Disease Treatment market has also been witnessing mergers and acquisitions. However, the presence of product counterfeits in the market could pose a challenge to the growth of this market.
TechNavio’s report, Global Infectious Disease Treatment Market 2011-2014, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the HIV/Aids, Hepatitis A, Hepatitis B, and Hepatitis C, Staph Infections, Antibiotic-resistant Infections, and Influenza landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include Bristol- Myers Squibb, GlaxoSmithKline Pharmaceutical Inc., Johnson & Johnson, Merck &Co. Inc., and Roche Pharmaceutical Inc.
Key questions answered in this report:
What will the market size be in 2014 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?
01. Executive Summary
02. Introduction
03. Market Coverage
04. Market Landscape
05. Vendor Landscape
06. Buying Criteria
07. Market Growth Drivers
08. Drivers and their Impact
09. Market Challenges
10. Market Trends
11. Key Vendor Analysis
11.1 GlaxoSmithKline Pharmaceuticals Ltd.
11.2 Bristol-Myers Squibb
11.3 Merck & Co. Inc.
11.4 Roche Pharmaceuticals Inc.
11.5 Johnson& Johnson
12. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Infectious Disease Treatment Market 2010–2014 (US$ billion)
Exhibit 2: Global Infectious Disease Treatment Market by Product Segmentation 2010
Exhibit 3: Global Infectious Disease Treatment Market by Treatment Segmentation 2010
Exhibit 4: Global Infectious Disease Treatment Market by Geographical Segmentation 2010
Exhibit 5: Global Infectious Disease Drugs Market by Vendor Segmentation 2010
| Title |
Date |
Price |
|
|
Jan 2013 |
$250.00 |
|
|
Oct 2009 |
$149.00 |
|
|
May 2010 |
$149.00 |
|
|
May 2010 |
$149.00 |
|
|
May 2010 |
$149.00 |
|
|
Jul 2010 |
$249.00 |
|
|
Jul 2010 |
$249.00 |
|
|
Jul 2010 |
$249.00 |
|
|
Oct 2010 |
$149.00 |
|
|
Oct 2010 |
$149.00 |
|
| |
|
|
|
For support please
contact:
US Toll Free
+1 888-789-6604
Asia Pacific
+91-9425069161
|
|
|
| |
|
| |
|
|
|
